추가 적립 안내

Carreyrou tells the story virtually to perfection . . . Bad Blood reads like a West Coast version of All the President’s Men. (New York Times)

Gripping . . . Carreyrou presents the scientific, human, legal and social sides of the story in full . . . He unveils many dark secrets of Theranos that have not previously been laid bare. (Nature)

Simply one of the best books about a startup ever. (Forbes)

Bad Blood reveals a crucial truth: outside observers must act as the eyes, the ears and, most importantly, the voice of Silicon Valley’s blind spot. Exaggerated promises, insular corporate cult culture and benevolent media coverage have allowed a monster to grow in the Valley. With Theranos, it gambled not with our smart phones, our attention or our democracy, but with people’s lives. (Paste)

'Chilling . . . Reads like a West Coast version of All the President’s Men.' New York Times Book Review

The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.

In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

Now to be adapted into a film, with Jennifer Lawrence to star.